Bookbot

Statistics: Textbooks and Monographs - 140: Statistics in the Pharmaceutical Industry

3rd Edition

Parámetros

  • 592 páginas
  • 21 horas de lectura

Más información sobre el libro

This rewritten and updated second edition provides comprehensive information on the wide-ranging applications of statistics in the pharmacological field. Focusing on practical aspects, it sets out to bridge the gap between industry and academia.;Reflecting the changes that have taken place since publication of the first edition, this volume covers new topics such as: cancer clinical trials, clinical trials of AIDS patients and animal tumorigenicity studies; the development of antiepileptic drugs; the role of epidemiology in postmarketing trials and adverse drug experience; computer-assisted new drug application (CANDA) submissions; contract research organizations; interim analysis in clinical trials; and room-temperature tests for the stability of drugs.;This work is intended as: a reference for statisticians, biostatisticians, pharmacologists, administrators, managers, and scientists in the pharmaceutical industry; and a text for graduate students taking courses in applied statistics or pharmaceutical statistics.

Compra de libros

Statistics: Textbooks and Monographs - 140: Statistics in the Pharmaceutical Industry, Charles Ralph Buncher, Jia-Yeong Tsay

Idioma
Publicado en
1993
product-detail.submit-box.info.binding
(Tapa dura),
Estado del libro
Dañado
Precio
5,42 €

Métodos de pago

Nadie lo ha calificado todavía.Añadir reseña

Título
Statistics: Textbooks and Monographs - 140: Statistics in the Pharmaceutical Industry
Subtítulo
3rd Edition
Idioma
Inglés
Editorial
CRC Press
Publicado en
1993
Formato
Tapa dura
Páginas
592
ISBN10
0824790731
ISBN13
9780824790738
Serie
Descripción
This rewritten and updated second edition provides comprehensive information on the wide-ranging applications of statistics in the pharmacological field. Focusing on practical aspects, it sets out to bridge the gap between industry and academia.;Reflecting the changes that have taken place since publication of the first edition, this volume covers new topics such as: cancer clinical trials, clinical trials of AIDS patients and animal tumorigenicity studies; the development of antiepileptic drugs; the role of epidemiology in postmarketing trials and adverse drug experience; computer-assisted new drug application (CANDA) submissions; contract research organizations; interim analysis in clinical trials; and room-temperature tests for the stability of drugs.;This work is intended as: a reference for statisticians, biostatisticians, pharmacologists, administrators, managers, and scientists in the pharmaceutical industry; and a text for graduate students taking courses in applied statistics or pharmaceutical statistics.